Navigation Links
R3 Stem Cell Now Offering Complimentary Cryogenic Freezer Program
Date:8/31/2018

R3 Stem Cell, the nation's leader in regenerative therapies, is now offering a complimentary cryogenic freezer program for new clients. The freezers are very convenient for practices to maintain regenerative biologics on hand for procedures.

The regenerative biologics from R3 Stem Cell consist of amniotic and umbilical cord tissue. They are stored at -80 degrees Celsius, which keeps the regenerative cells viable.

Most of the time, practices order the biologic material once a procedure is scheduled. This mandates a delay, and also makes it difficult on certain days of the week to receive them.

By having a stem cell freezer in the practice, this concern disappears. The freezers offered by R3 Stem Cell have a small footprint and fit underneath a counter, yet hold plenty of the biologic material. They are maintained by R3, with continuous probes checking the temperature and providing web based alerts when necessary. The freezers are fully warrantied, and cost nothing up front.

R3 assists practices nationwide with stem cell marketing, treatment protocols, seminars, biologics, videos and more. After 10,000 successful stem cell procedures at over 30 centers nationwide, R3 is the nation's leader in regenerative therapies.

Many conditions benefit from the regenerative procedures, including arthritis, autoimmune conditions, neurodegenerative disease and organ failure too. No harvesting is necessary from the patient, and the risks are absolutely minimal.

To find out more about the R3 Stem Cell Parnership Program, visit https://r3stemcell.com/become-a-provider/ or call (844) GET-STEM.

Read the full story at https://www.prweb.com/releases/r3_stem_cell_now_offering_complimentary_cryogenic_freezer_program/prweb15726857.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. innerCore Offering Sensorys TrulySecure Biometric Technology as Part of its Security Packages
2. Zimmer Biomet Prices Offering of Euro-Denominated Senior Notes
3. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
4. Infosys Finacle Partners with Onegini to Strengthen Digital Banking Offering
5. Worldcore - The Worlds First EU-regulated Payment Institution Offering Voice Biometrics Authentication
6. Nxt-ID, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
7. WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million
8. Pfenex Inc. Announces Pricing Of Initial Public Offering
9. UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies
10. Complimentary press registration now open for ACMG 2014 Annual Clinical Genetics Meeting
11. The Regenerative Medicine Institute Concludes 2018 with their "Clinical Staff Program" and "Hands-On Stem Cell and Adipose Procedures and Aspirations Training"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2019)... ... February 05, 2019 , ... ... announced it has partnered with MindFuel, a leading organization in educational science, technology, ... education. Amino Labs has pioneered a syn-bio starter kit for teachers ...
(Date:1/30/2019)... ... January 30, 2019 , ... ... high-growth, high-impact life science and biotechnology companies, announced today that it will ... and disease-focused venture funds to discuss their investment philosophies, explain their fund ...
(Date:1/21/2019)... ... January 20, 2019 , ... Energetiq Technology, a world leader in high ... the SPIE BIOS and SPIE Photonics West events taking place in San Francisco on ... #8526 at Bios and in booth #941 at Photonics West. There will be live ...
Breaking Biology News(10 mins):
(Date:2/6/2019)... ... February 05, 2019 , ... ... the Firmex executive management team to acquire Firmex, one of the fastest-growing and ... Novacap, a Montreal-based private equity firm. Debt financing was provided by the Bank ...
(Date:2/2/2019)... France (PRWEB) , ... February 01, 2019 , ... ... is pleased to announce the appointment of its new CEO, Julien Dert, being ... 25 years of international experience in finance and management, in which more than ...
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, ... dosing of the first patient in a phase 1/2 clinical study of ACTUS-101 ... with high morbidity and often leads to premature death. There are variable ...
(Date:1/30/2019)... FRANCISCO (PRWEB) , ... January 30, 2019 , ... ... leader in microbial genomics, has awarded microbiome research support in study design, planning, ... State University led by Dr. Marc D. Cook, PhD, to study the interactions ...
Breaking Biology Technology: